EPITHELIAL-TO-MESENCHYMAL TRANSITION INHIBITOR AND CANCER METASTASIS THERAPEUTIC AGENT

摘要

PROBLEM TO BE SOLVED: To provide a molecule that exhibits EMT inhibitory effect as an active ingredient of a pharmaceutical composition for treating and/or preventing cancer metastasis.SOLUTION: The present invention provides an agent for inhibiting the transition from an epithelial cell (excluding gastric adenocarcinoma-derived cell) to a mesenchymal cell, comprising a nucleic acid having a base sequence encoding Prdm16, or a pharmaceutical composition for preventing and/or treating the metastasis of cancer (excluding gastric adenocarcinoma), comprising a nucleic acid having a base sequence encoding Prdm16.SELECTED DRAWING: None